Search medicines and health products

Crocin 650 mg Tablet.Uses | Dosage form | Safety measurements | Side effects.

Crocin 650 Tablet.



                    





  BUY NOW           


                
     

Manufactured by: GSK labs ltd.


Composition : Paracetamol/Acetaminophen-650mg


MRPRs-30.34





Uses of Crocin Tablet :


Dolo Tablet is used for pain relief and fever. It is used to relieve pain in conditions like headaches, joint pain, muscle pain, or dental pain. 

Side effects of Crocin Tablet :


No common side effect is seen. 

How to use Crocin Tablet 


Take this medicine in the dose as prescribed by the physician. Do not chew it, swallow as a whole. It does not have any type of interaction with food, so it can be taken with food.

Mechanism of  CrocinTablet : 


Crocin 650 tablet is an analgesic (pain reliever) and anti-pyretic (fever reducer). It works by blocking the release of certain chemical messengers that is responsible for producing pain and fever. 


Safety measurements :


#  It is unsafe to administered Crocin Tablet with
    alcohol.

#  It is safe to administer during pregnancy. The effect produced by Crocin Tablet on developing babies is seen to be very low.

 It is safe to administer during breastfeeding because it does not pass into breast milk.

#  It does not produce dizziness during the drive.

#  It should be used with caution in patients with        liver and kidney disease after consulting with
    Doctor.


     The other brands with the same salts   (composition).


 MEDICINES BRAND     M.R.P      
DOLO  650mg Tablet.             (Cipla Ltd)                  30.40        
PARACIP 650 mg Tablet.       (Micro labs)           40.25          
P 650 mg Tablet.      (Apex lab Pvt ltd.)      55.26 
CALPOL 650 mg Tablet         (GSK)                          20.00        
MACFAST 650 mg Tablet.      (Macleods) 42.10 
XYKA RAPID 650 mg Tablet. (Troika)                        16.26       
CROCIN 650mg Tablet G.S.K 30.40 



            

  

             

.         

        

   

No comments:

Post a Comment